Jazz Pharmaceuticals plc

Connor, Clark & Lunn Investment Management Ltd. JAZZ

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

6,041

Value ($000)

1,027

Weight

0.0%

2014 Q1 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	1,027	0.0%	6,041	12/31/2025
2025 Q3	11/13/2025	12,280	0.0%	93,173	9/30/2025
2025 Q2	8/7/2025	14,960	0.1%	140,972	6/30/2025
2025 Q1	5/12/2025	16,439	0.1%	132,415	3/31/2025
2024 Q4	2/10/2025	13,800	0.1%	112,055	12/31/2024
2024 Q3	11/8/2024	2,076	0.0%	18,633	9/30/2024
2024 Q2	8/9/2024	2,533	0.0%	23,735	6/30/2024
2024 Q1	5/9/2024	15,777	0.1%	131,016	3/31/2024
2023 Q4	2/9/2024	22,591	0.1%	183,663	12/31/2023
2023 Q3	11/13/2023	22,835	0.1%	176,416	9/30/2023
2023 Q2	8/10/2023	29,616	0.1%	238,893	6/30/2023
2023 Q1	5/10/2023	33,077	0.2%	226,042	3/31/2023
2022 Q4	2/10/2023	33,935	0.2%	213,014	12/31/2022
2022 Q3	11/10/2022	16,440	0.1%	123,343	9/30/2022
2022 Q2	8/5/2022	13,650	0.1%	87,494	6/30/2022
2022 Q1	5/12/2022	10,303	0.1%	66,187	3/31/2022
2021 Q4	2/10/2022	9,736	0.0%	76,419	12/31/2021
2021 Q3	11/12/2021	5,321	0.0%	40,867	9/30/2021
2014 Q1	5/14/2014	6,781	0.0%	44,300	3/31/2014